JEFFERY R. AJER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

NEKTAR THERAPEUTICS

Filing Date Source Excerpt
2019-04-30 Jeff Ajer, age 56, was appointed to the board of directors of in September 2017. Mr. Ajer currently serves as Executive Vice President and Chief Commercial Officer at BioMarin Pharmaceutical Inc. ... With the passing away of Mr. Krivulka on February 17, 2018, and the appointment of Karin Eastham effective as of September 26, 2018, the Organization and Compensation Committee consists of four independent directors: Messrs. Ajer, Greer and Lingnau and Ms. Eastham. ... The following table shows compensation awarded or paid to our non-employee directors for the fiscal year ended December 31, 2018. ... Jeff Ajer Fees Earned or Paid in Cash $92,250, Stock Awards $289,322, Option Awards $327,479, Total $709,051.

Data sourced from SEC filings. Last updated: 2026-02-03